happygamestation.online


Boston Scientific Stock Forecast

Analyst Price Targets ; ; Average ; Current ; High. The current price of BSX is USD — it has decreased by −% in the past 24 hours. Watch Boston Scientific Corporation stock price performance more. Boston Scientific is forecast to grow earnings and revenue by % and % per annum respectively. EPS is expected to grow by % per annum. Return on. The analysts offering price forecasts for Boston Scientific have a median target of , with a high estimate of and a low estimate of The. Get Boston Scientific Corp (BSX:NYSE) real-time stock quotes, news, price and financial information from CNBC.

While ratings are subjective and will change, the latest Boston Scientific (BSX) rating was a maintained with a price target of $ to $ The current. The 21 analysts with month price forecasts for Boston Scientific stock have an average target of , with a low estimate of 60 and a high estimate of Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. on a frequent basis to provide recommendations along with target share price. 37 analysts offering month price forecasts for Boston Scientific Corp. (BSX). Is Boston Scientific Corporation stock A Buy? Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as. Based on analysts offering 12 month price targets for BSX in the last 3 months. The average price target is $ with a high estimate of $ and a low. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BSX will report Analysts' recommendations: Boston Scientific Corporation · Citigroup Adjusts Price Target on Boston Scientific to $92 From $90, Maintains Buy · Barclays Adjusts. See the latest Boston Scientific Corp stock price (BSX:XNYS), related news, valuation, dividends and more to help you make your investing decisions. InvestorsStockHistorical Price Lookup. Main Content. Historical Price Lookup. Select share(s). Boston Scientific Corporation. Share Price Lookup; Share Price.

BSX's current price target is $ Learn why top analysts are making this stock forecast for Boston Scientific at MarketBeat. Latest BSX news ; am ET Boston Scientific price target raised to $92 from $90 at Citi ; am ET Bullish Outlook: Boston Scientific Earns 'Buy' Rating with. The Boston Scientific stock prediction for is currently $ , assuming that Boston Scientific shares will continue growing at the average yearly rate as. Rewards · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Earnings grew by % over the past year. The 21 analysts with month price forecasts for Boston Scientific stock have an average target of , with a low estimate of 60 and a high estimate of Key Stock Data · P/E Ratio (TTM). (08/23/24) · EPS (TTM). $ · Market Cap. $ B · Shares Outstanding. B · Public Float. B · Yield. BSX is. Based on short-term price targets offered by 28 analysts, the average price target for Boston Scientific comes to $ The forecasts range from a low of. Based on 22 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is € with a high. On average, Wall Street analysts predict that Boston Scientific's share price could reach $ by Aug 22, The average Boston Scientific stock price.

The average one-year price target for Boston Scientific Corporation is $ The forecasts range from a low of $ to a high of $ A stock's. Boston Scientific Stock Forecast · Over the next 52 weeks, Boston Scientific has on average historically risen by % based on the past 32 years of stock. Boston Scientific (BSX) stock price prediction is USD. The Boston Scientific stock forecast is USD for August Boston Scientific (BSX) Q4 Earnings Call Transcript. BSX earnings call for the period ending December 31, Motley Fool Transcribing | Feb. Boston Scientific Corp. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range -

Passive Income Business Models | Marcus By Goldman Sachs Cd Reviews

14 15 16 17 18

Copyright 2011-2024 Privice Policy Contacts SiteMap RSS